Avanos Medical (NYSE:AVNS) announced today that it appointed David Pacitti as its new CEO, effective April 14, 2025.

Abbott Laboratories' medical device business is executing well, with double-digit growth in structural heart and diabetes.

An update from Avanos Medical ( ($AVNS) ) is now available. On March 17, 2025, Avanos Medical announced the appointment of David Pacitti as its ...

Siemens Healthineers’ president of the Americas, David Pacitti, is leaving the imaging giant to become CEO of the devicemaker ...

Abbott Laboratories engages in the discovery ... The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular ...

and Abbott (NYSE: ABT). With a proven track record of driving revenue growth, expanding market share, and fostering strategic partnerships, he will play a critical role in scaling Cagent Vascular ...